The authors evaluated associations between intakes of folate and vitamin B 6 and colorectal cancer risk among women enrolled in a randomized trial on aspirin and vitamin E in disease prevention. At baseline (1992)(1993)(1994)(1995), 37,916 US women aged 45 years who were free of cancer and cardiovascular disease provided dietary information. During an average of 10.1 years of follow-up (through February 20, 2004), 220 colorectal adenocarcinoma cases were documented. Total folate and vitamin B 6 intakes were not significantly associated with the risk of colorectal cancer. However, dietary intakes of folate and vitamin B 6 were significantly inversely associated with colorectal cancer risk among women who were not taking supplements containing folate and vitamin B 6 . Multivariable relative risks among women in the highest quintiles of intake versus the lowest were 1.16 (95% confidence interval (CI): 0.76, 1.79) for total folate, 1.14 (95% CI: 0.77, 1.69) for total vitamin B 6 , 0.46 (95% CI: 0.26, 0.81) for dietary folate, and 0.69 (95% CI: 0.41, 1.15) for dietary vitamin B 6 . The use of multivitamin supplements was not related to colorectal cancer risk. These findings suggest that higher dietary intakes of folate and vitamin B 6 may reduce the risk of colorectal cancer in women. An alternative explanation is that other factors related to dietary intakes of folate and vitamin B 6 account for the inverse associations. colorectal neoplasms; dietary supplements; folic acid; vitamin B 6; vitamins; women Abbreviation: CI, confidence interval.
chromosome breaks and disruption of DNA repair (2, 6, 7) . In addition, recent data from cell culture and animal studies have suggested that vitamin B 6 may prevent the development of colon cancer through several other mechanisms, including the suppression of cell proliferation, oxidative stress, nitric oxide synthesis, and angiogenesis (8) .
Although findings from prospective cohort studies and case-control studies generally suggest an inverse association between folate intake and risk of colorectal cancer, the data are not entirely consistent (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) . In addition, data relating vitamin B 6 intake to the risk of colorectal cancer are limited. Thus, we conducted a prospective analysis of folate and vitamin B 6 intakes and the risk of colorectal cancer in a large cohort of women.
MATERIALS AND METHODS

Study cohort
The Women's Health Study was established in 1992 when 39,876 female US health professionals aged 45 years or older who were free of cancer and cardiovascular disease at baseline were enrolled in a randomized, double-blind, placebo-controlled clinical trial evaluating the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cancer (other than nonmelanoma skin cancer) and cardiovascular disease (29) . Upon enrollment in the study, all participants completed a baseline questionnaire about their medical history and lifestyle characteristics, including potential risk factors for colorectal cancer. The current analysis was restricted to 37,916 women after exclusion of those who did not provide dietary information, had implausible total energy intakes (<600 kcal/day or >3,500 kcal/day), did not provide information on use of multivitamin supplements, or had newly diagnosed nonadenocarcinoma colorectal cancer.
Dietary assessment
At baseline, 39,345 (98.7 percent) women in the Women's Health Study completed a 131-item food frequency questionnaire, a format that has been used in the Nurses' Health Study. The questionnaire assessed average consumption over the past year of a specific amount of each food and allowed nine responses, ranging from ''never'' to ''six or more times per day.'' Nutrient intake was calculated by multiplying the frequency response by the nutrient content of the specified portion size. The food frequency questionnaire included a section on current use of multivitamin supplements; this section was completed by 96.6 percent of the women. Participants were asked about the exact brand and type of multivitamins they used and how many times they took multivitamins per week (2, 3-5, 6-9, or 10). Intakes of folate and vitamin B 6 from supplements were estimated by linking this information with a comprehensive database on the folate and vitamin B 6 content of multivitamin preparations that was created by the Department of Nutrition at the Harvard School of Public Health. Information about the status (never, past, or current) and duration (0-1, 2-4, 5-9, 10-14, 15-19, or 20 years) of multivitamin supplement use was collected in the baseline enrollment questionnaire.
The validity and reliability of the food frequency questionnaire has been assessed in the Nurses' Health Study (30) (31) (32) (33) , which has many characteristics similar to those of the Women's Health Study. In a sample of 188 participants from the Nurses' Health Study, the correlation coefficients for correlation between folate intakes calculated from the 1980 dietary questionnaire and erythrocyte folate concentrations in 1987 were 0.55 for total folate (folate from both foods and supplements) and 0.38 for dietary folate (folate from foods only) (34) . In a sample of 712 participants who provided blood specimens during 1989-1990 and served as controls in a nested case-control study of breast cancer within the Nurses' Health Study, the correlation coefficients for correlation between average intakes of folate and vitamin B 6 calculated from the 1980, 1984, 1986 , and 1990 food frequency questionnaires and plasma levels were 0.49 for total folate and 0.52 for total vitamin B 6 (35) . The corresponding correlation coefficients for dietary folate and dietary vitamin B 6 after exclusion of supplement users were 0.33 and 0.25, respectively (35) .
Ascertainment of colorectal cancer cases
Every 6 months during the first year of follow-up and then annually thereafter, participants were sent questionnaires asking about newly diagnosed diseases, including colon or rectal cancer, and other clinical endpoints. Deaths of participants were identified through reports from family members, postal authorities, and a search of the National Death Index. To date, follow-up rates for morbidity and mortality are 95 percent and 97 percent, respectively. For participants who reported a diagnosis of colorectal cancer and for those who were deceased, we sought medical records and other relevant information. This information was reviewed by an Endpoints Committee consisting of physicians for confirmation of medical diagnoses. Medical record review confirmed 96 percent of the self-reports.
Statistical analysis
For nutrient analysis, women were categorized into quintiles of nutrient intake, with adjustment for total energy by means of the residual method to reduce measurement errors due to general over-or underreporting of food items (33) . For the analysis by tumor location (proximal colon, distal colon, and rectum), women were categorized into tertiles because of the modest numbers of cases.
We compared the distributions of baseline data on risk factors for colorectal cancer by quintiles of total folate and total vitamin B 6 intake to assess their potential for confounding. Person-years were calculated for each participant, ranging from the date of randomization to the date of confirmed cancer diagnosis, death, or February 20, 2004 , whichever occurred first. Cox proportional hazards regression models were used to calculate relative risks and 95 percent confidence intervals. We first estimated the relative risks according to category of nutrient intake, with adjustment for age (in years) and randomized treatment assignment (aspirin vs. placebo, vitamin E vs. placebo). We further performed a multivariate analysis that additionally adjusted for known or potential risk factors for colorectal cancer, including body mass index (weight (kg)/height (m) 2 ; <23, 23-<25, 25-<27, 27-<30, or 30); family history of colorectal cancer in a first-degree relative (yes, no); history of self-reported colon polyps at baseline (yes, no); physical activity (kcal/week, in quartiles); smoking status (never, past, or current); red meat intake (servings/day, in tertiles); alcohol consumption (0, >0-<15, or 15 g/day); total energy intake (kcal/day, in quintiles); menopausal status (premenopausal, postmenopausal, or uncertain/unknown); baseline postmenopausal hormone use (never, past, or current); and aspirin use before the trial (yes, no).
In additional analyses, we excluded incident colorectal cancer cases diagnosed within the first 2 years of followup, with further adjustment for the use of colonoscopy or sigmoidoscopy for regular screening (yes, no), which participants were asked about in the 12-month follow-up questionnaire. We conducted analyses of total and dietary folate intake stratified by level of alcohol consumption (<75th percentile (<5.0 g/day) or 75th percentile (5.0 g/day)) to evaluate whether the association between folate intake and colorectal cancer risk might exist among persons who consumed more alcohol. Because alcohol is a known folate antagonist (36, 37) , women who consume alcohol may have a higher requirement for folate. We conducted tests for interaction between folate and alcohol intake in relation to colorectal cancer risk by using the median value for each quintile of folate intake to form a continuous variable, an indicator variable for alcohol intake (<5 g/day vs. 5 g/day), and an interaction term for the product of these two variables. We used the Wald test to assess the statistical significance of the multiplicative interaction term. Because multivitamins are major sources of supplemental folate and vitamin B 6 , we also evaluated the relation between use of multivitamin supplements at baseline and risk of colorectal cancer. Use of multivitamin supplements was categorized according to status (never, past, or current use), frequency of current use (none, five or fewer times per week, or more than five times per week), and duration of past or current use (<2, 2-4, 5-9, or 10 years). We performed tests for trend using the median value for each nutrient category to form a continuous variable. All p values were two-sided.
RESULTS
The median duration of follow-up was 10.1 years between 1992 and February 20, 2004. During follow-up, 220 incident cases of invasive colorectal cancer were confirmed, including 89 cases of proximal colon cancer, 82 cases of distal colon cancer, 44 cases of rectal cancer, and five cases for which the site in the colon was not specified. Median baseline intakes were 348 lg/day for total folate, 307 lg/day for dietary folate, 2.3 mg/day for total vitamin B 6 , and 2.0 mg/day for dietary vitamin B 6 . Fifty-seven percent of the women had taken multivitamin supplements in the past, and 29 percent were taking multivitamin supplements currently. Table 1 presents the distributions of baseline data on risk factors for colorectal cancer according to quintiles of total intake of folate and vitamin B 6 . Women who consumed more total folate and total vitamin B 6 tended to be current users of multivitamins; 78 percent of women in the highest category of total folate intake and 75 percent of women in the highest category of total vitamin B 6 intake were current users of multivitamin supplements. Women who consumed more total folate and total vitamin B 6 tended to be older, leaner, more physically active, and more likely to currently use postmenopausal hormones and aspirin before the trial, but they were less likely to be current smokers and to report a family history of colorectal cancer in a first-degree relative. Women with greater total folate and vitamin B 6 intakes also tended to undergo colonoscopy or sigmoidoscopy for screening or symptoms, to consume less alcohol and red meat, and to consume more dietary fiber. Personal histories of colon polyps did not appear to differ significantly according to intakes of total folate and total vitamin B 6 .
While intakes of total folate and total vitamin B 6 were not significantly associated with the risk of colorectal cancer, an inverse association was observed for intakes of dietary folate and dietary vitamin B 6 6 (p for trend ¼ 0.14). In addition, an apparent threshold effect of dietary folate and vitamin B 6 was observed; a reduced risk of colorectal cancer was observed in the second and fifth quintiles of dietary folate and in the higher three quintiles of dietary vitamin B 6 (table 2). The multivariable relative risk comparing women in the higher three quintiles of dietary vitamin B 6 with those in the lower two quintiles was 0.66 (95 percent CI: 0.47, 0.93). When dietary intakes of folate and vitamin B 6 were evaluated jointly, the multivariable relative risks were 0.42 (95 percent CI: 0.21, 0.86) for women in the highest quintiles of both dietary folate and vitamin B 6 and 0.60 (95 percent CI: 0.38, 0.96) for women in other quintiles of both, as compared with those in the lowest quintiles of both. There was no significant association between methionine intake and the risk of colorectal cancer (table 2) .
The associations between intakes of either total or dietary folate and the risk of colorectal cancer did not appear to differ according to level of alcohol intake; the multivariable p values for interaction were 0.40 for total folate and 0.58 for dietary folate. However, the number of cases in this analysis was limited.
The use of multivitamin supplements at baseline was not significantly associated with the risk of colorectal cancer; the multivariable relative risks were 0.94 (95 percent CI: 0.64, 1.37) for past users and 1.07 (95 percent CI: 0.72, 1.61) for current users (table 3) . The use of multivitamin supplements for 10 or more years or six or more times per week was also not significantly associated with the risk of colorectal cancer.
In an additional analysis, we excluded cases diagnosed within the first 2 years of follow-up to address the potential bias that women might have changed their diets because of preclinical symptoms of colorectal cancer; the associations with folate, vitamin B 6 , and multivitamin supplements did not change appreciably (data not shown). In addition, in the analysis by tumor location, there were no clear patterns for intakes of dietary folate and dietary vitamin B 6 or for the use of multivitamin supplements. However, positive associations between total folate and total vitamin B 6 intakes and the risk of distal colon cancer were observed. The multivariable relative risks comparing the highest tertile of total folate intake with the lowest were 0.75 (95 percent CI: 0. 45 
DISCUSSION
In this large cohort of women, we observed no association between total folate and vitamin B 6 intakes and the risk of colorectal cancer. However, we found an inverse association between dietary intakes of folate and vitamin B 6 and the risk of colorectal cancer among women who did not take these supplements.
Because of the prospective design, recall or selection biases are unlikely to explain our findings in this study, and the high follow-up rates minimize the concern that differential rates of follow-up affected our results. Symptoms of colorectal cancer might have caused some women to increase their intake of vitamins before clinical diagnosis. However, the similar results observed after exclusion of colorectal cancer cases diagnosed within the first 2 years of follow-up do not support this explanation. Although confounding by unknown variables cannot be excluded, it seems unlikely, because adjustment for a number of potential risk factors for colorectal cancer had a minimal effect on the relative risks. Estimates of nutrient intake calculated from the food frequency questionnaire are subject to measurement error. Such error is likely to have been nondifferential because of our prospective design and may have resulted in attenuation of risk estimates. Since we assessed intakes of nutrients only at baseline, measurement error due to random within-person variation may have been inevitable. Finally, because the number of events was relatively modest, we had limited statistical power for stratified analyses and analyses of tumor locations.
Although the available data are not totally consistent, the findings from prospective cohort studies that have evaluated the relation between folate intake and risk of colorectal * Values for some categories overlap because of rounding. y Adjusted for age and randomized treatment assignment. z Adjusted for age, randomized treatment assignment, body mass index, family history of colorectal cancer in a first-degree relative, history of colon polyps, physical activity, smoking status, red meat intake, alcohol consumption, total energy intake, menopausal status, baseline postmenopausal hormone use, and baseline aspirin use.
§ Additionally adjusted for use of multivitamin supplements.
cancer suggest an inverse association (9-18), particularly among persons with high alcohol consumption. In the Nurses' Health Study, women with folate intakes of more than 400 lg/day were found to have a significantly lower (31 percent) risk of colon cancer than women with intakes of less than 200 lg/day (11). Furthermore, women who had been taking folic acid-containing multivitamins for 15 or more years were 75 percent less likely to develop colon cancer than were women who did not take multivitamins (11) . Two (12, 38) of three (10, 12, 38) prospective studies have also suggested that high blood levels of folate are related to reduced risk of colorectal cancer. A number of investigators have conducted case-control studies of folate intake and colorectal cancer risk (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) ; most have found a lower risk of colorectal cancer associated with higher folate intake (19) (20) (21) (22) (25) (26) (27) . In comparison with some other North American cohorts (39), the level of alcohol consumption in the Women's Health Study cohort was lower, which may have limited our power to detect a difference in the folate-colorectal cancer association by level of alcohol intake. Few studies have assessed the relation between vitamin B 6 and colorectal cancer risk. In the Nurses' Health Study, plasma vitamin B 6 concentration was inversely associated with the risks of colorectal cancer and adenoma (40) . In the Iowa Women's Health Study, a higher vitamin B 6 intake was not independently associated with the risk of colon cancer, but it was significantly inversely associated with proximal colon cancer when combined with a high folate intake (15) . In several case-control studies, investigators reported a lower risk of colorectal cancer associated with a higher vitamin B 6 intake (19, 24, 26) . However, in two other studies, no overall associations were observed (28, 41) .
Our findings suggesting a possible inverse relation of colorectal cancer risk with intakes of dietary folate and dietary vitamin B 6 rather than total folate and total vitamin B 6 are intriguing. Such findings are consistent with results from a recent meta-analysis of seven cohort studies and nine case-control studies on folate intake and colorectal cancer risk, which found a stronger inverse association for dietary folate than for total folate (42) . However, these findings for folate seem to conflict with the fact that folic acid used in supplements is in the form of monoglutamate, which bypasses deconjugation for intestinal absorption and is thus more bioavailable than dietary folate (43) . One possible explanation is that dietary nutrient intakes (intakes from (11) . Because of the small number of cases, we were unable to evaluate the risk of colorectal cancer among participants who had used multivitamin supplements for 15 or more years. Another possible explanation is that folate and vitamin B 6 may reduce the risk of colorectal cancer among women whose diets are low in these vitamins. Our observation of inverse associations for dietary folate and dietary vitamin B 6 among women not taking these supplements appears to support such an explanation. It is also consistent with the apparent threshold effect observed for dietary folate and dietary vitamin B 6 (i.e., low intake increases risk but incremental intake above the threshold level may add minimum benefits). Because vitamin supplements are typically taken in excess of dietary intake, their removal from the analysis would strengthen the association between dietary folate or dietary vitamin B 6 intake and the risk of colorectal cancer.
An alternative explanation for the present observations, however, is that dietary intake of folate or vitamin B 6 may merely serve as a marker for other constituents of foods that are rich in folate or vitamin B 6 (such as fiber or other potentially protective constituents) or lifestyle factors related to risk of colorectal cancer. In our analysis, additionally controlling for dietary fiber slightly attenuated the associations for dietary folate. Null associations between total intakes of folate and vitamin B 6 and colorectal cancer risk might also be a result of surveillance bias, because of increased use of colonoscopy or sigmoidoscopy procedures among supplement users. However, this explanation is not supported by the unchanged results from the analysis excluding colorectal cancer cases diagnosed within the first 2 years of follow-up, in which the use of colonoscopy or sigmoidoscopy was included in multivariable models. In a subgroup analysis of tumor locations, we also observed an increased risk associated with total intakes of folate and vitamin B 6 for distal colon cancer but not for proximal colon and rectal cancer. However, because we had a limited number of cases in this analysis, these findings should be interpreted with caution.
Although both the Women's Health Study and the Nurses' Health Study consisted of female health professionals, participants in the Women's Health Study were enrolled much later (1992 vs. 1976 ) and had healthier diets. More than half of the follow-up in the Women's Health Study took place after mandatory fortification of grain products with folic acid in the United States (44) . Approximately half of participants in the Women's Health Study consumed at least 400 lg/day of total folate (Dietary Reference Intake of folate for adults (45) ) at baseline. In contrast, only 29 percent of participants in the Nurses' Health Study consumed this amount of total folate at baseline (11) . In addition, alcohol consumption in the Nurses' Health Study (39) was almost twice as high as that in the Women's Health Study. These factors may have contributed to the discrepancy in results from these two studies.
The data from the present study support recommendations to improve folate and vitamin B 6 intakes from dietary sources for colorectal cancer prevention. However, the null data for multivitamin supplements alone cannot be definitely viewed as suggesting no role for multivitamin supplements in reducing risk, since some other studies have reported an inverse association between multivitamin supplement use and colorectal cancer risk, especially among long-term users (9, 11, 25) . On the other hand, the null findings on use of multivitamin supplements argue against their playing a major role in colorectal cancer prevention.
In summary, the findings from this large prospective cohort study of women suggest that higher dietary intakes of folate and vitamin B 6 may reduce the risk of colorectal cancer in women. However, an alternative explanation is that other factors related to dietary intakes of folate and vitamin B 6 may account for the inverse associations.
